1. Home
  2. ANVS vs FEIM Comparison

ANVS vs FEIM Comparison

Compare ANVS & FEIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Annovis Bio Inc.

ANVS

Annovis Bio Inc.

HOLD

Current Price

$4.18

Market Cap

111.3M

Sector

Health Care

ML Signal

HOLD

Logo Frequency Electronics Inc.

FEIM

Frequency Electronics Inc.

HOLD

Current Price

$46.98

Market Cap

348.4M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANVS
FEIM
Founded
2008
1961
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Electrical Products
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
111.3M
348.4M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
ANVS
FEIM
Price
$4.18
$46.98
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
1
Target Price
$13.50
$43.00
AVG Volume (30 Days)
4.0M
253.9K
Earning Date
11-12-2025
12-11-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
163.74
EPS
N/A
2.17
Revenue
N/A
$69,852,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$17.90
P/E Ratio
N/A
$21.44
Revenue Growth
N/A
16.06
52 Week Low
$1.11
$13.69
52 Week High
$6.37
$48.35

Technical Indicators

Market Signals
Indicator
ANVS
FEIM
Relative Strength Index (RSI) 56.39 80.83
Support Level $4.12 $27.32
Resistance Level $4.64 $36.48
Average True Range (ATR) 0.53 2.55
MACD -0.11 1.86
Stochastic Oscillator 23.89 95.56

Price Performance

Historical Comparison
ANVS
FEIM

About ANVS Annovis Bio Inc.

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.

About FEIM Frequency Electronics Inc.

Frequency Electronics Inc is engaged in the design, development, and manufacture of high-precision timing, and frequency control products for space, air, sea, and terrestrial applications. The company has FEI-NY and FEI-Zyfer reportable segments. It derives the majority of its revenues from the FEI-NY segment. FEI-NY segment operations consist principally of precision time and frequency control products used in three principal markets namely communication satellites (both commercial and U.S. Government-funded); terrestrial cellular telephone or other ground-based telecommunication stations; and other components and systems for the U.S. military.

Share on Social Networks: